This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. When Madrigal Pharmaceuticals secured its history-making ...

Madrigal (shoulder) cleared waivers and opted for free agency Thursday. Madrigal missed the full 2025 campaign after undergoing surgery in February to repair a fractured left shoulder. The infielder, ...

Shares of Madrigal Pharmaceuticals (MDGL) traded sharply higher for the second straight session on Wednesday after Cantor Fitzgerald upgraded the company, arguing that the commercial rollout of its ...

Madrigal Pharmaceuticals' Rezdiffra generated sales of $287 million in the third quarter for a 35% sequential jump from Q2. In just its fifth full quarter on the market, the world’s first treatment ...

Net Sales: $287.3 million, up 35% quarter over quarter. Patients on Therapy: More than 29,500 patients, up from over 23,000 in the previous quarter. Prescribers: Over 10,000 healthcare providers have ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Join Post Sports+ for exciting subscriber-only features, including real-time texting with Greg Joyce about the inside buzz on the Yankees. Camilo Doval was brought in by the Yankees as a former closer ...

Bullpens win World Series titles, and the New York Yankees appear to be acting with that knowledge. The Yankees are acquiring pitcher Camilo Doval from the San Francisco Giants, according to a ...

July 30 (Reuters) - U.S. drugmaker Madrigal Pharmaceuticals (MDGL.O), opens new tab has struck a licensing deal with CSPC Pharmaceutical Group (1093.HK), opens new tab that could be worth more than $2 ...

Madrigal Pharmaceuticals is paying $120 million upfront for a preclinical GLP-1 receptor agonist that the biopharma plans to pair up with its approved fatty liver disease med Rezdiffra. The GLP-1 drug ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Madrigal Pharmaceuticals inks $2 ...

In trading on Wednesday, shares of Madrigal Pharmaceuticals Inc (Symbol: MDGL) crossed above their 200 day moving average of $294.07, changing hands as high as $300.94 per share. Madrigal ...